Cargando…

Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis

Background: It is well known that the cerebrospinal fluid (CSF) concentrations of free light chains (FLC) and immunoglobulin G (IgG) are elevated in multiple sclerosis patients (MS). Therefore, in this study we aimed to develop a model based on the concentrations of free light chains and IgG to pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gudowska-Sawczuk, Monika, Tarasiuk, Joanna, Kułakowska, Alina, Kochanowicz, Jan, Mroczko, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349504/ https://www.ncbi.nlm.nih.gov/pubmed/32471086 http://dx.doi.org/10.3390/brainsci10060324

Ejemplares similares

COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review
por: Bazylewicz, Marcin, et al.
Publicado: (2023)

Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2019)

Free Light Chains κ and λ as New Biomarkers of Selected Diseases
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2023)

The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2022)

The Clinical Significance of Serum Free Light Chains in Bladder Cancer
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2023)

Free Immunoglobulin Light Chains in Patients with Tick-Borne Encephalitis: Before and after Treatment
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2021)

Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2022)

Co-occurrence of Fatigue and Depression in People With Multiple Sclerosis: A Mini-Review
por: Tarasiuk, Joanna, et al.
Publicado: (2022)

Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination
por: Czarnowska, Agata, et al.
Publicado: (2023)

Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2020)

Selected Biomarkers of Tick-Borne Encephalitis: A Review
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2021)

What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2022)

The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2021)

Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland
por: Kapica-Topczewska, Katarzyna, et al.
Publicado: (2021)

Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern
por: Zeman, David, et al.
Publicado: (2012)

Intrathecal kappa free light chains as markers for multiple sclerosis
por: Vecchio, D., et al.
Publicado: (2020)

The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
por: Arneth, Borros, et al.
Publicado: (2022)

The Role of Chemokine Receptor CXCR3 and Its Ligands in Renal Cell Carcinoma
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2020)

The FOXP3 rs3761547 Gene Polymorphism in Multiple Sclerosis as a Male-Specific Risk Factor
por: Wawrusiewicz-Kurylonek, Natalia, et al.
Publicado: (2018)

The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
por: Konen, Franz Felix, et al.
Publicado: (2021)

Severe tick-borne encephalitis in a patient recovered from COVID 19
por: Czarnowska, Agata, et al.
Publicado: (2022)

Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity
por: Berek, Klaus, et al.
Publicado: (2021)

Kappa free light chains index in multiple sclerosis very long-term prognosis
por: Arroyo-Pereiro, Pablo, et al.
Publicado: (2023)

The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review
por: Kulikowska, Joanna, et al.
Publicado: (2021)

IgA nephropathy in IgG kappa multiple myeloma
por: Couto, Maria Eduarda, et al.
Publicado: (2021)

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2022)

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
por: Hegen, Harald, et al.
Publicado: (2022)

Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease
por: Grados, Aurélie, et al.
Publicado: (2013)

The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2018)

Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis
por: Menéndez-Valladares, P, et al.
Publicado: (2015)

Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing–remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2023)

Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern
por: Hannich, Malte Johannes, et al.
Publicado: (2021)

Higher Content but No Specific Activity in Gelatinase B (MMP-9) Compared with Gelatinase A (MMP-2) in Human Renal Carcinoma
por: Młynarczyk, Grzegorz, et al.
Publicado: (2023)

High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
por: Castillo-Villalba, Jéssica, et al.
Publicado: (2022)

Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study
por: Hegen, Harald, et al.
Publicado: (2023)

Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
por: Hegen, Harald, et al.
Publicado: (2022)

High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2023)

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis
por: Hegen, Harald, et al.
Publicado: (2022)

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study
por: Levraut, Michael, et al.
Publicado: (2022)

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
por: Monreal, Enric, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7hdf60uv1d0j80mto7h5rnbqjr